Palvella Therapeutics rakes in $45m Series C
Wayne, Pennsylvania-based Palvella Therapeutics Inc., a rare disease biopharmaceutical company, has raised $45 million in Series C financing.
Wayne, Pennsylvania-based Palvella Therapeutics Inc., a rare disease biopharmaceutical company, has raised $45 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination